Figure 2From: Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer Kaplan-Meier estimation of relapse-free survival a) overall population; b) dose level 3.Back to article page